» Articles » PMID: 39144801

Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia

Abstract

Background: 22q11.2 Deletion Syndrome (22q11DS) represents one of the most important genetic risk factors for schizophrenia (SCZ) and a reliable biological model to study endophenotypic characters of SCZ. The aim of the study was to investigate Social Cognition impairments in subjects with 22q11.2DS compared to a considerable sample of schizophrenic patients.

Methods: Forty-four individuals with 22q11.2DS (DEL) and 18 patients with 22q11.2DS and psychosis (DEL_SCZ) were enrolled; these groups were compared to 887 patients with schizophrenia (SCZ) and 780 healthy controls (HCs); the latter groups were recruited by the Italian Network for Research on Psychoses (NIRP) to which our Centre took part. Social cognition was evaluated through The Awareness of Social Inference Test (TASIT). A resampling procedure was employed to balance differences in samples size.

Results: All clinical groups (DEL; DEL_SCZ; and SCZ) showed worse performance on TASIT than HCs, except in scale. No differences between-clinical groups were found, except for and scales.

Conclusions: SC was impaired in individuals with 22q11.2DS regardless of psychotic symptomatology, similarly to people with SCZ. Therefore, SC deficits may represent potential endophenotypes of SCZ contributing to the vulnerability to psychosis.

Citing Articles

Real-Life Functioning in 22q11.2 Deletion Syndrome in Relation to Neurocognitive Abilities and Psychotic Symptoms: A Comparison With Idiopathic Schizophrenia.

Accinni T, Frascarelli M, Cordellieri P, Kotzalidis G, Fanella M, Di Bonaventura C J Intellect Disabil Res. 2024; 69(3):177-192.

PMID: 39614621 PMC: 11791388. DOI: 10.1111/jir.13200.


Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia.

Pezzella P, Caporusso E, Mucci A, Bucci P, Giordano G, Amore M Schizophr Bull Open. 2024; 5(1):sgae020.

PMID: 39221412 PMC: 11362673. DOI: 10.1093/schizbullopen/sgae020.


Neuroanatomical Correlates of Cognitive Dysfunction in 22q11.2 Deletion Syndrome.

Smerconish S, Schmitt J Genes (Basel). 2024; 15(4).

PMID: 38674375 PMC: 11050060. DOI: 10.3390/genes15040440.

References
1.
McDonald-McGinn D, Sullivan K, Marino B, Philip N, Swillen A, Vorstman J . 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2016; 1:15071. PMC: 4900471. DOI: 10.1038/nrdp.2015.71. View

2.
Pontillo M, Menghini D, Vicari S . Neurocognitive profile and onset of psychosis symptoms in children, adolescents and young adults with 22q11 deletion syndrome: A longitudinal study. Schizophr Res. 2019; 208:76-81. DOI: 10.1016/j.schres.2019.04.012. View

3.
Devoe D, Farris M, Townes P, Addington J . Interventions and social functioning in youth at risk of psychosis: A systematic review and meta-analysis. Early Interv Psychiatry. 2018; 13(2):169-180. DOI: 10.1111/eip.12689. View

4.
Mucci A, Galderisi S, Green M, Nuechterlein K, Rucci P, Gibertoni D . Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives. Psychol Med. 2017; 48(8):1359-1366. DOI: 10.1017/S0033291717002902. View

5.
Blakemore S, Choudhury S . Development of the adolescent brain: implications for executive function and social cognition. J Child Psychol Psychiatry. 2006; 47(3-4):296-312. DOI: 10.1111/j.1469-7610.2006.01611.x. View